Archive for November 15th, 2008

Internal Medicine News - Wellbutrin XL.(NEW & APPROVED)(Brief article)

Saturday, November 15th, 2008

Wellbutrin XL

(bupropion extended release, GlaxoSmithKline)

An antidepressant for preventing seasonal major depressive episodes in people with seasonal affective disorder (SAD). The first drug approved for a SAD-related indication. Previously approved for major depressive disorder and smoking cessation.

* Recommended Dosage: Start at 150 mg/day; if tolerated, increase to 300 mg/day after 1 week. In studies, treatment continued through the winte…